Detalles de la búsqueda
1.
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies.
Lancet
; 396(10266): 1885-1894, 2020 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33308471
2.
Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment.
Blood
; 127(6): 713-21, 2016 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26631116
3.
Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma.
Eur J Clin Pharmacol
; 72(2): 153-61, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26494130
4.
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial.
Lancet Oncol
; 15(11): 1195-206, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25242045
5.
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial.
Lancet Haematol
; 9(11): e833-e843, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36228643
6.
From single-arm studies to externally controlled studies. Methodological considerations and guidelines.
Therapie
; 75(1): 21-27, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32063399
7.
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 136: 116-129, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32688206
8.
Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial.
Lancet Haematol
; 3(11): e506-e515, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27751707
9.
Des études mono-bras aux études de comparaison externe. Considérations méthodologiques et recommandations.
Therapie
; 75(1): 13-19, 2020.
Artículo
en Francés
| MEDLINE | ID: mdl-32063401
Resultados
1 -
9
de 9
1
Próxima >
>>